ASCO 2015 Highlights

Oncology navigators should attend because the AVBCC Summit provides an opporutnity to come together as one unified voice and also to hear from others in the field, said Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+).

Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties, said her organization is interested in practice transformation and value-based care and AVBCC is the "best conference ever" to meet the individuals who can address questions about value-based care.

Understanding how other institutions, practices, and companies are envisioning the future of value-based care is an invaluable benefit, and the chance to network with others is "priceless," said Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties.

Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties, said she wishes to share her insights gleaned through data analytics at the meeting because they may be helpful to others.

Every independent practice should be able to transform into value-based care, said Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties, who spoke about data analytics and her experience with her own practice.

The AVBCC Summit brings together physicians and other stakeholders to brainstorm and create the best solutions, said Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties.

Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties, encourages others to attend for the opportunites for brainstorming and networking.

Peter Tun, Manager, Magnolia Innovation, says that he wants to see every patient get the care they need without cost barriers. This would include using precision medicine to deliver the best care possible at the lowest cost.

As we learn more about precision medicine and how to identify biomarkers, Peter Tun, Manager, Magnolia Innovation, would like to see more discussion among stakeholders on how to optimize these findings in future gatherings.

The AVBCC Summit is a great opportunity to hear from different stakeholders and meet some very brilliant people, said Peter Tun, Manager, Magnolia Innovation. And, it offers the chance to focus on the changing oncology landscape.